Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients

Clinical trial NCT02235519 · UNKNOWN

Trial details

NCT number: NCT02235519
Sponsor: Hospital General de México Dr. Eduardo Liceaga
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hypertension Obesity Type 2 Diabetes Mellitus

Start date: 2014-01-01
Primary completion: 2015-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.